Multiple effects of CDK4/6 inhibition in cancer: From cell cycle arrest to immunomodulation

This publication has 94 references indexed in Scilit:

• Targeting normal and cancer senescent cells as a strategy of senotherapy
  Ageing Research Reviews, 2019
• Palbociclib Effectively Halts Proliferation but Fails to Induce Senescence in Patient-Derived Glioma Stem Cells
  Molecular Neurobiology, 2019
• Molecular mechanisms of resistance to CDK4/6 inhibitors in breast cancer: A review
  International Journal of Cancer, 2018
• The metabolic function of cyclin D3–CDK6 kinase in cancer cell survival
  Nature, 2017
• E2F1 enhances glycolysis through suppressing Sirt6 transcription in cancer cells
  Oncotarget, 2015
• MDM2 turnover and expression of ATRX determine the choice between quiescence and senescence in response to CDK4 inhibition
  Oncotarget, 2015
• Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
  Science Signaling, 2013
• Cyclin D1 Determines Mitochondrial Function InVivo
  Molecular and Cellular Biology, 2006
• Mammalian Cells Cycle without the D-Type Cyclin-Dependent Kinases Cdk4 and Cdk6
  Cell, 2004
• Mouse Development and Cell Proliferation in the Absence of D-Cyclins
  Cell, 2004